BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2558622)

  • 1. [Evaluation of the effectiveness of a cicletanine-enalapril combination in hypertensive patients].
    Safar M; Cournot P; Duchier J
    Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():119-24. PubMed ID: 2558622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cicletanine administered with other antihypertensive agents].
    Grimberg D; Tarrade T; Deschamps de Paillette E
    Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():109-12. PubMed ID: 2575368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antihypertensive effectiveness and tolerance of cicletanine. Results obtained with bitherapy].
    Tarrade T; Berthet P; Paillasseur JL; Bosquet D; Allard M
    Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():103-8. PubMed ID: 2575367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antihypertensive effectiveness and tolerance of cicletanine. Results obtained with monotherapy in a large population].
    Tarrade T; Berthet P; Paillasseur JL; Bosquet D; Allard M
    Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():91-7. PubMed ID: 2514675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of three studies to determine the efficacy and tolerance of cicletanine in the short- and long-term treatment of essential hypertension.
    Fodor GP; Guinot P
    Drugs Exp Clin Res; 1988; 14(2-3):195-204. PubMed ID: 3046883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of the effectiveness and tolerance of cicletanine in patients with essential hypertension treated with beta-blockers].
    Clerson P; Deltour L; Billaut P; Tarrade T; Berthet P; Pauchant M
    Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():113-8. PubMed ID: 2575369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of rhythm tolerance of cicletanine using continuous electrocardiographic recording].
    Witchitz S; Gryner S
    Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():145-9. PubMed ID: 2514655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dose-effectiveness relationship of cicletanine at short-term in moderately to severely hypertensive patients].
    Fritel D
    Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():99-102. PubMed ID: 2514676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hypotensive effectiveness of therapy combined enalapril and nitrendipine and influence on the quality of life].
    Bryl W; Cymerys M; Kujawska-Luczak M; Pupek-Musialik D
    Pol Merkur Lekarski; 2005 Mar; 18(105):287-90. PubMed ID: 15997634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerance of cicletanine, a new antihypertensive agent: overview of 1226 treated patients.
    Tarrade T; Guinot P
    Drugs Exp Clin Res; 1988; 14(2-3):205-14. PubMed ID: 3046884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cicletanine tolerance in hypertensive patients with metabolic disorders].
    Passa P
    Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():135-8. PubMed ID: 2514653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative study of 2 dosages of a new antihypertensive agent, cicletanine, in elderly subjects].
    Jungers P; Gavardin T; Salom M; Tarrade T; Berthet P
    Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():125-9. PubMed ID: 2514651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enalapril as first choice treatment of mild, moderate and severe essential hypertension: results of an open multicentre clinical trial. New Zealand Hypertension Study Group.
    N Z Med J; 1987 Mar; 100(819):137-9. PubMed ID: 2837697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, controlled, multicenter study to compare prazosin GITS with enalapril in hypertensive patients with diabetes mellitus. Bombay Hypertension Study Group.
    Joglekar SJ; Nanivadekar AS
    J Assoc Physicians India; 1998; Suppl 1():52-62. PubMed ID: 11233387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical and vascular effects of ACE inhibitor enalapril in combination with thiaside-like diuretic indapamide in hypertensive outpatients. Results of the multicenter trial POEMA].
    Belenkov IuN; Ageev FT; Orolova IaA; Abrosimova OIu; Volkova EG; Gapon LI; Katel'nitskaia LI; Kondari AO; Patrusheva IF; Fomin IV; Khokhlov RA
    Ter Arkh; 2007; 79(8):33-8. PubMed ID: 17926468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased efficacy and tolerability with losartan plus hydrochlorothiazide in patients with uncontrolled hypertension and therapy-related symptoms receiving two monotherapies.
    Naidoo DP; Sareli P; Marin F; Aroca-Martinez G; Maritz FJ; Jardim PC; Guerrero AA; Thompson CA; Bero T; Drazka J; Kosmalova V; Dumortier T; Smith RD
    Adv Ther; 1999; 16(5):187-99. PubMed ID: 10915394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood pressure-lowering efficacy of amiloride versus enalapril as add-on drugs in patients with uncontrolled blood pressure receiving hydrochlorothiazide.
    Guerrero P; Fuchs FD; Moreira LM; Martins VM; Bertoluci C; Fuchs SC; Gus M
    Clin Exp Hypertens; 2008 Oct; 30(7):553-64. PubMed ID: 18855259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of the optimal dose of the antihypertensive drug cicletanine hydrochloride in man.
    Guinot P; Jewitt-Harris J; Tarrade T
    Arzneimittelforschung; 1989 Jan; 39(1):86-9. PubMed ID: 2655611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of delapril plus manidipine compared with enalapril plus hydrochlorothiazide in mild to moderate essential hypertension: results of a randomized trial.
    Mugellini A; Dobovisek J; Planinc D; Cremonesi G; Fogari R
    Clin Ther; 2004 Sep; 26(9):1419-26. PubMed ID: 15531004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.